ESQlabs Submits Detailed Public Comment Letter to FDA on Draft Guidance for New Approach Methodologies in Drug Development
2026-06-03
PubComNonGov2026-06-03
Carter Struck
WASHINGTON, June 3 -- ESQlabs GmbH, Saterland, Germany, a contract research organization specializing in computational and in vitro approaches to drug development, has submitted a public comment lette . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, June 3 -- ESQlabs GmbH, Saterland, Germany, a contract research organization specializing in computational and in vitro approaches to drug development, has submitted a public comment lette . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026